0001209191-21-021450.txt : 20210317 0001209191-21-021450.hdr.sgml : 20210317 20210317173350 ACCESSION NUMBER: 0001209191-21-021450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210315 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rutten Guillaume Marie Jean CENTRAL INDEX KEY: 0001596796 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29472 FILM NUMBER: 21751772 MAIL ADDRESS: STREET 1: 1900 S. PRICE ROAD CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMKOR TECHNOLOGY, INC. CENTRAL INDEX KEY: 0001047127 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 231722724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2045 EAST INNOVATION CIRCLE CITY: TEMPE STATE: AZ ZIP: 85284 BUSINESS PHONE: 480-821-5000 MAIL ADDRESS: STREET 1: 2045 EAST INNOVATION CIRCLE CITY: TEMPE STATE: AZ ZIP: 85284 FORMER COMPANY: FORMER CONFORMED NAME: AMKOR TECHNOLOGY INC DATE OF NAME CHANGE: 19971001 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-15 0 0001047127 AMKOR TECHNOLOGY, INC. AMKR 0001596796 Rutten Guillaume Marie Jean 2045 EAST INNOVATION CIRCLE TEMPE AZ 85284 1 1 0 0 President and CEO Common Stock 2021-03-15 4 M 0 9375 9.86 A 434375 D Common Stock 2021-03-15 4 S 0 9375 22.47 D 425000 D Common Stock 2021-03-15 4 M 0 5625 9.48 A 430625 D Common Stock 2021-03-15 4 S 0 5625 22.47 D 425000 D Employee Stock Option (Right-to-Buy) 9.86 2021-03-15 4 M 0 9375 0.00 D 2018-02-27 2027-02-27 Common Stock 9375 0 D Employee Stock Option (Right-to-Buy) 9.48 2021-03-15 4 M 0 5625 0.00 D 2020-02-15 2029-02-15 Common Stock 5625 96537 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.32 to $22.61. This stock option was granted on February 27, 2017 and vests as follows: 25% of the shares vest on the first anniversary of the grant date and 1/16 of the option vests each quarter thereafter, such that 100% of the option will vest on the fourth anniversary of the grant date. This stock option was granted on February 15, 2019 and vests as follows: 25% of the shares vest on the first anniversary of the grant date and 1/16 of the option vests each quarter thereafter, such that 100% of the option will vest on the fourth anniversary of the grant date. John D. Montanti, Attorney-in-Fact for Guillaume Marie Jean Rutten 2021-03-17 EX-24.4_973936 2 poa.txt POA DOCUMENT Know all by these presents, that the undersigned hereby makes, constitutes and appoints Mark N. Rogers and John D. Montanti (either of whom may act individually) as the undersigned's true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Amkor Technology, Inc., a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and (3) perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirements of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of February, 2021. /Guillaume Marie Jean Rutten/ Guillaume Marie Jean Rutten